Cryptogenic ischemic stroke and prevalence of asymptomatic atrial fibrillation: A prospective study

Journal of Cardiovascular Medicine

Volumn 17, Issue 12, 2016, Pages 863-869

  Jorfida, Marcella ^a   Antolini, Marina ^a   Cerrato, Enrico ^a   Caprioli, Maria Giovann ^a   Castagno, Davide ^a   Garrone, Paolo ^a   Budano, Carlo ^a   Cerrato, Paolo ^b   Gaita, Fiorenzo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Atrial fibrillation; Cardiac monitoring; Cryptogenic stroke; Implantable loop recorder; Supraventricular arrhythmia

Indexed keywords

AGED; ARTICLE; ASYMPTOMATIC DISEASE; BRAIN ISCHEMIA; CRYPTOGENIC ISCHEMIC STROKE; DISEASE DURATION; DYSPNEA; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART PALPITATION; HUMAN; IMPLANTABLE CARDIAC MONITOR; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PAROXYSMAL ATRIAL FIBRILLATION; PROSPECTIVE STUDY; UNIVARIATE ANALYSIS; WEAKNESS; AMBULATORY ELECTROCARDIOGRAPHY; ASYMPTOMATIC DISEASES; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; COMPLICATION; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; ISCHEMIC ATTACK, TRANSIENT; KAPLAN MEIER METHOD; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SECONDARY PREVENTION; TACHYCARDIA, SUPRAVENTRICULAR;

AGED; ASYMPTOMATIC DISEASES; ATRIAL FIBRILLATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SECONDARY PREVENTION; STROKE; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 84912035663     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000181     Document Type: Article

References (38)

1. Zhang Y, Chapman AM, Plested M, et al. The incidence, prevalence, and mortality of Stroke in France, Germany, Italy, Spain, the UK, and the US: a literature review. Stroke Res Treat 2012; 2012:436125.
2. Rosamond W, Flegal K, Furie K, et al. Heart Disease and Stroke Statistics- 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117:25-146.
3. Dhamoon MS, Sciacca RR, Rundek T, Sacco RL, Elkind MS. Recurrent stroke and cardiac risks after first ischemic stroke, The Northern Manhattan Study. Neurology 2006; 66:641-646.
4. Guercini F, Acciarresi M, Agnelli G, Paciaroni M. Cryptogenic stroke: time to determine aetiology. J Thromb Haemostasis 2008; 6:549-554.
5. Marini C, De Santis F, Sacco S, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 2005; 36:1115-1119.
6. Karataş M, Dilek A, Erkan H, Yavuz N, Sözay S, Akman N. Functional outcome in stroke patients with atrial fibrillation. Arch Phys Med Rehabil 2000; 81:1025-1029.
7. Seet RC, Friedman PA, Rabinstein AA. Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause. Circulation 2011; 4:477-486.
8. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42:227-276.
9. Hart RG, Pearce LA, Koudstaal PJ. Transient ischemic attacks in patients with atrial fibrillation: implications for secondary prevention: the European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial. Stroke 2004; 35:948-951.
10. O'Donnell M, Oczkowski W, Fang J, et al. Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study. Lancet Neurol 2006; 5:749-754.
11. Marnane M, Duggan CA, Sheehan OC, et al. Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke study. Stroke 2010; 41:1579-1586.
12. Al-Buhairi AR, Phillips SJ, Llewellyn G, Jan MM. Prediction of infarct topography using the Oxfordshire Community Stroke Project classification of stroke subtypes. J Stroke Cerebrovasc Dis 1998; 7:339-343.
13. Smith CJ, Emsley HC, Libetta CM, et al. The Oxfordshire Community Stroke Project classification in the early hours of ischemic stroke and relation to infarct site and size on cranial computed tomography. J Stroke Cerebrovasc Dis 2001; 10:205-209.
14. Schoonderwoerd B, Smit M, Pen L, Van Gelder I. New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'. Europace 2008; 10:668-673.
15. Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis Scott Med J 1957; 5:200-215.
16. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7:79-108.
17. Amarenco P, Bogousslavsky J, Caplan LR, et al. New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis 2009; 27:502-508.
18. Pristipino C, Anzola GP, Ballerini L, et al. Management of patients with patent foramen ovale and cryptogenic stroke: a collaborative, multidisciplinary, position paper. Catheter Cardiovasc Interv 2013; 82:E38-E51.
19. Hindricks G, Pokushalov E, Urban L, et al. Performance of a new implantable cardiac monitor in detecting and quantifying atrial fibrillation - results of the XPECT trial. Circ Arrhythm Electrophysiol 2010; 3:141-147.
20. Eitel C, Husser D, Hindricks G, et al. Performance of an implantable automatic atrial fibrillation detection device: impact of software adjustments and relevance of manual episode analysis. Europace 2011; 13:480-485.
21. Liao J, Khalid Z, Scallan C, Morillo C, O'Donnell M. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter following acute ischemic stroke: a systematic review. Stroke 2007; 38:2935-2940.
22. Cotter PE, Martin PJ, Ring L, Warburton EA, Belham M, Pugh PJ. Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke. Neurology 2013; 80:1546-1550.
23. Grond M, Jauss M, Hamann G, et al. Improved detection of silent atrial fibrillation using 72-h Holter ECG in patients with ischemic stroke: a prospective multicenter cohort study. Stroke 2013; 44:3357-3364.
24. Sinha AM, Diener HC, Morillo CA, et al. Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): design and rationale. Am Heart J 2010; 160(1):36-41.e1.
25. Flint AC, Banki NM, Ren X, Rao VA, Go AS. Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: the Stroke and Monitoring for PAF in Real Time (SMART) Registry. Stroke 2012; 10:2788-2790.
26. Manina G, Agnelli G, Becattini C, et al. 96 h ECG monitoring for patients with ischemic cryptogenic stroke or transient ischaemic attack. Intern Emerg Med 2014; 9:65-67.
27. Ritter MA, Kochhäuser S, Duning T, et al. Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors. Stroke 2013; 44:1449-1452.
28. Glotzer TV, Hellkamp AS, Zimmerman J, et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 2003; 107:1614-1619.
29. Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012; 366:120-129.
30. Botto GL, Padeletti L, Santini M, et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 2009; 20:241-248.
31. Boriani G, Botto GL, Padeletti L, et al. Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring. Stroke 2011; 42:1768.
32. Dion F, Saudeau D, Bonnaud I, et al. Unexpected low prevalence of atrial fibrillation in cryptogenic ischemic stroke: a prospective study. J Interv Card Electrophysiol 2010; 28:101-107.
33. Camm AJ, Corbucci G, Padeletti L. Usefulness of continuous electrocardiographic monitoring for atrial fibrillation. Am J Cardiol 2012; 110:270-276.
34. Björck S, Palaszewski B, Friberg L, Bergfeldt L. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study. Stroke 2013; 44:00-10.
35. Flaker GC, Belew K, Beckman K, et al. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005; 149:657-663.
36. Hohnloser SH, Pajitnev D, Pogue J, et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVEWSubstudy. J Am Coll Cardiol 2007; 50:2156-2161.
37. Bonvini RF, Sztajzel R, Dorsaz PA, et al. Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke. Int J Stroke 2010; 5:4-9.
38. Hart SA, Krasuski RA. Incidence of asymptomatic patent foramen ovale according to age. Ann Intern Med 2009; 150:431-432.